Earnings
GWPH
218.96
-0.15%
-0.32
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2020-12-31
-58.13M
12.76M
-2.65M
--
--
--
59.80M
--
--
-39.16M
--
-27.39M
-28.01M
--
--
--
-6.40M
-28.01M
1.58M
-882.00K
--
--
--
--
--
--
-1.13M
6.34M
-50.18M
FY 2019-12-31
-9.02M
9.24M
-9.70M
--
--
--
-53.34M
--
--
-60.65M
--
-123.47M
-42.49M
--
--
--
104.12M
61.63M
2.88M
-932.00K
--
--
--
--
--
--
1.95M
5.33M
-54.56M
FY 2018-09-30
-295.17M
9.29M
-317.00K
--
--
--
36.78M
--
--
17.54M
--
-231.87M
-33.40M
--
--
--
517.00K
-32.89M
298.55M
-798.00K
--
--
--
--
--
--
297.75M
-240.00K
32.76M
FY 2017-09-30
-174.82M
7.33M
--
--
--
--
-6.57M
--
--
27.71M
--
-146.35M
-22.16M
--
--
--
1.90M
-20.26M
127.44K
-1.39M
--
--
--
--
--
--
-2.73M
-7.51M
-176.85M
FY 2017-09-30
-183.16M
7.68M
-3.77M
--
--
--
-6.89M
--
--
29.03M
--
-153.34M
-23.22M
--
--
--
1.99M
-21.23M
-52.85K
-1.46M
--
--
--
--
--
--
-2.86M
-7.87M
-185.29M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out GWPH latest annual and quarterly financial reports. There are also historical financial reports for you to reference. You can analyze GW Pharma recent business situations by check its cash flow statements, balance sheets, income statements and other tables. Comprehensive data may help you to understand and analyze GWPH development prospects in various aspects, and this information may help you to better grasp the GW Pharma operation.